Healthcare
Our Healthcare & Life Sciences team provides a full suite of investment banking, corporate finance, advisory, research, and sales and trading services to companies across the sector. We bring diverse experience, strategic insight, and a collaborative approach to working with innovative companies that are developing novel therapies, diagnostics, devices, and services to improve outcomes for patients.
Representative sector experience and coverage include:
- Biotech
- Diagnostics
- Digital Health
- Healthcare Technology
- Hospital & Health Systems
- Life Science Tools
- Medical Devices
- Outsourced Pharmaceutical Services
Providers & Provider Services
Specialty Pharma & Biopharma
Featured Transactions
May 2024
Eastside Endoscopy Center
an affiliate of
has been acquired by
Sell-Side Advisor
November 2023
$50,000,000
Common Stock
At-the-Market Offering
Distribution Agent
November 2023
$50,000,000
Common Stock
At-the-Market Offering
Sole Distribution Agent
November 2023
$28,750,000
Common Stock
Follow-On Offering
Co-Manager
November 2023
$100,000,000
Common Stock
At-the-Market Offering
Sole Distribution Agent
August 2023
$75,000,000
Common Stock
At-the-Market Offering
Lead Distribution Agent
August 2023
$500,000,000
Common Stock
At-the-Market Offering
Distribution Agent
November 2022
Financial Advisor
November 2022
Financial Advisor
November 2022
Financial Advisor
November 2022
Financial Advisor
September 2022
$400,000,000
Distribution Agent
June 2022
Exclusive Financial Advisor
April 2022
$20,700,000
Bookrunning Manager
January 2022
$27,520,250
Bookrunning Manager
December 2021
$5,000,000,000
Joint Agent
December 2021
Exclusive Financial Advisor
October 2021
$51,999,996
Lead Bookrunning Manager
September 2021
$35,000,000
Bookrunning Manager
September 2021
$23,000,004
Sole Bookrunning Manager
August 2021
Strategic and Financial Advisor
August 2021
Exclusive Financial Advisor
July 2021
$40,000,000
Sole Bookrunning Manager
July 2021
Exclusive Financial Advisor
June 2021
$500,000,000
Sole Agent
June 2021
$20,000,000
Bookrunner
May 2021
$51,750,001
Sole Bookrunning Manager
May 2021
$58,803,600
Bookrunner
April 2021
$55,000,000
Bookrunner
April 2021
$40,000,000
Bookrunning Manager
March 2021
Investment Banker
March 2021
Sell-side Advisor
February 2021
$50,000,010
Bookrunning Manager
January 2021
Exclusive Financial Advisor
December 2020
$44,803,391
Bookrunning Manager
December 2020
$24,600,000
Bookrunning Manager
August 2020
$48,875,000
Bookrunning Manager
July 2020
$27,600,000
Bookrunning Manager
December 2019
$40,250,000
Bookrunner
These examples from B. Riley Securities, inclusive of legacy FocalPoint Partners, are provided for illustrative purposes only and there are no guarantees that any of the strategies or offering types cited will be successful in the future. Each offering type is highly dependent on a variety of factors including, but not limited to: the type of offering; the manner in which the transaction is marketed; the sector into which the underlying company belongs; the depth and breadth the market or market sector, the offering price and general financial conditions. Information provided does not represent a recommendation, solicitation or offer to buy or sell any security.